ALEXANDRIA, Va., Aug. 22 /PRNewswire/ -- Recently the anti-obesity drug
phentermine hydrochloride has been in short supply, causing difficulties for
patients who take this medication, as well as the physicians and pharmacists
who prescribe or sell it. To help health care professionals and patients who
are having trouble stocking phentermine or filling a prescription, OBESITY
MEDS AND RESEARCH NEWS (OMR) published two comprehensive articles in April and
August of this year which are available on-line at http://www.obesity-
news.com/.
Our August coverage included:
-- An interview with the manufacturer of raw phentermine powder and
detailed information on its production schedule.
-- An exhaustive list of every known manufacturer and distributor of
phentermine including which companies are producing it and have stock.
The list contains addresses, telephone numbers and links to web sites
(where available).
Highlights of our April coverage included:
-- Interviews with the manufacturers of phentermine powder, phentermine
hydrochloride and phentermine resin.
-- A history of the events leading up to the phentermine shortage.
-- A timetable as to when the shortage will be over.
-- How to find phentermine during the crisis.
-- A primer on how drugs shortages occur, and how to find out if a rumor
is a hoax or the real thing.
Both articles can be ordered individually from our web site, and can be
accessed with an on-line subscription to OMR.
OBESITY MEDS AND RESEARCH NEWS is a monthly, plain-language newsletter
with the latest information on obesity research and weight loss medication
development. OMR's quality summaries of published research and conference
presentations are read by health care professionals and patients around the
world.
Our newsletter features an annual drugs in development issue each fall
covering anti-obesity medications coming to market over the next few years,
and the latest gene discoveries. Other features of the OMR web site include an
exclusive obesity primer, OBESITY 101, and a second newsletter, OMR OBESITY
UPDATE.
SOURCE OBESITY MEDS AND RESEARCH NEWS
 back to top
Related links:
http://www.obesity-news.com
CONTACT:
Barbara Hirsch, Publisher of OBESITY MEDS AND
RESEARCH NEWS, 703-960-3649
|
